Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis

被引:50
|
作者
Sun, Bin [1 ]
Huang, Zhi [2 ]
Wang, Bi [3 ]
Yu, Yanglong [4 ]
Lin, Shihai [1 ]
Luo, Lei [1 ]
Wang, Yuzhu [1 ]
Huang, Zheng [1 ]
机构
[1] First Peoples Hosp Guiyang, Dept Intervent Radiol, Guiyang, Guizhou, Peoples R China
[2] Guizhou Med Univ, Affiliated Baiyun Hosp, Dept Intervent Radiol, Guiyang, Guizhou, Peoples R China
[3] Maternal & Child Hlth Hosp Guiyang City, Dept Prepotency, Guiyang, Guizhou, Peoples R China
[4] Guizhou Med Univ, Dept Clin Med, Guiyang, Guizhou, Peoples R China
来源
MEDICAL SCIENCE MONITOR | 2017年 / 23卷
关键词
Antifreeze Proteins; Type II; Type III; Genes; rev; Headache Disorders; Primary; MART-1; Antigen; CELL-PROLIFERATION; CARCINOMA TISSUES; HEPATITIS; THERAPY; MARKER;
D O I
10.12659/MSM.899198
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Primary hepatocellular carcinoma (HCC) is a malignant tumor that is common China. Early diagnosis is of great significance for improving treatment efficiency. GPC3 level is closely related to HCC occurrence. This study investigated GPC3 expression in HCC patient serum and tissue, and assessed the significance of GPC3 combined AFP detection in HCC diagnosis. Material/Methods: A total of 76 HCC patients in our hospital were enrolled. Immunohistochemistry was applied to test GPC3 expression in cancer tissue and para-carcinoma tissue. ELISA and RT-PCR were used to detect GPC3 and AFP level in serum. The significance of GPC3 single or combined AFP detection in HCC diagnosis was analyzed. Results: Immunohistochemistry showed that the GPC3 positive expression rate was obviously elevated in HCC tissue (P<0.01). Combination detection of AFP and GPC3 presented significantly higher sensitivity and specificity in HCC than single AFP or GPC3 detection. ELISA showed no significant difference in sensitivity, specificity, or accuracy compared with RT-PCR. Conclusions: Serum GPC3 was overexpressed in HCC patients. Combination detection of serum AFP and GPC3 can enhance accuracy and efficacy of HCC diagnosis.
引用
收藏
页码:850 / 855
页数:6
相关论文
共 50 条
  • [1] An Assessment of the Heterogeneous Expression of Glypican-3 (GPC3) in Hepatocellular Carcinoma (HCC) in the Era of GPC3 as a Biomarker
    Cox, Brian
    Waters, Kevin
    Dhall, Deepti
    Larson, Brent
    Guindi, Maha
    LABORATORY INVESTIGATION, 2019, 99
  • [2] An Assessment of the Heterogeneous Expression of Glypican-3 (GPC3) in Hepatocellular Carcinoma (HCC) in the Era of GPC3 as a Biomarker
    Cox, Brian
    Waters, Kevin
    Dhall, Deepti
    Larson, Brent
    Guindi, Maha
    MODERN PATHOLOGY, 2019, 32
  • [3] Glypican-3 (GPC3) expression in hepatocellular carcinomas and preneoplastic liver lesions
    Xiao, X. Y.
    Dubois, S.
    Tessiore, S.
    Degos, F.
    Belghiti, J.
    Allegretta, M.
    Guttmann, R.
    Bedossa, P.
    Paradis, V.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S107 - S107
  • [4] A correlation between Glypican-3 (GPC3) expression and the grading system in hepatocellular carcinoma
    Herlea, V.
    Procop, A.
    Pechianu, C.
    Mihai, M.
    Mustafa, E. Stoica
    Hortopan, M.
    Iorgescu, A.
    Andreoiu, O. -M.
    Varban, S.
    Popescu, I.
    VIRCHOWS ARCHIV, 2017, 471 : S134 - S134
  • [5] Expression of Glypican-3 (GPC3) in breast cancer tumors from Brazilian and Argentinean patients
    Lago Huvelle, Maria A.
    Maia, Aline
    Fujita, Andre
    Armanasco, Eduardo
    Bagnoli, Fabio
    de Oliveira, Vilmar Marques
    Longo Galvao Silva, Maria A.
    de Kier Joffe, Elisa Bal
    Sogayar, Mari C.
    Puricelli, Lydia
    Labriola, Leticia
    Peters, Maria G.
    CANCER RESEARCH, 2012, 72
  • [6] Glypican-3 (GPC3) expression in human placenta: localization to the differentiated syncytiotrophoblast
    Khan, S
    Blackburn, M
    Mao, DL
    Huber, R
    Schlessinger, D
    Fant, M
    HISTOLOGY AND HISTOPATHOLOGY, 2001, 16 (01) : 71 - 78
  • [7] Glypican-3 (GPC3) signaling pathway involved in breast cancer progression
    Fernandez, Dolores
    Cercato, Magali
    Guereno, Macarena
    Peters, Maria G.
    CANCER RESEARCH, 2018, 78 (13)
  • [8] Immunological efficacy of glypican-3 (GPC3) peptide vaccine in patients with advanced hepatocellular carcinoma
    Tsuchiya, Nobuhiro
    Yoshikawa, Toshiaki
    Fujinami, Norihiro
    Saito, Keigo
    Shimomura, Manami
    Suzuki, Toshihiro
    Nosaka, Kazuto
    Shimizu, Hiroyasu
    Akazawa, Yu
    Charneau, Jimmy
    Sawada, Yu
    Endo, Itaru
    Nakatsura, Tetsuya
    CANCER SCIENCE, 2018, 109 : 276 - 276
  • [9] Expression pattern of glypican-3 (GPC3) during human embryonic and fetal development
    Iglesias, Bibiana V.
    Centeno, Gloria
    Pascuccelli, Hector
    Ward, Flavia
    Peters, Maria Giselle
    Filmus, Jorge
    Puricelli, Lydia
    Joffe, Elisa Bal de Kier
    HISTOLOGY AND HISTOPATHOLOGY, 2008, 23 (11) : 1333 - 1340
  • [10] Expression of glypican-3 (GPC 3) and its significance as a novel marker of the degree of dedifferentiation in hepatocellular carcinoma
    Fukuzawa, Y
    Furuta, K
    Tagaya, T
    Sato, K
    Maeno, T
    Ayada, M
    Hotta, N
    Okumura, A
    Ishikawa, T
    Kakumu, S
    HEPATOLOGY, 2002, 36 (04) : 691A - 691A